![](/img/cover-not-exists.png)
PCN7 THE LIFETIME COST OF GEFITINIB (“IRESSA”) IN TREATING PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC)
A Haiderali, W ChinVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65741-5
File:
PDF, 63 KB
english, 2004